A high soy diet reduces programmed cell death and enhances bcl-xL expression in experimental stroke

Neuroscience

Volumn 148, Issue 3, 2007, Pages 644-652

  Lovekamp Swan, T ^a   Glendenning, M ^a   Schreihofer, D A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

apoptosis; bcl 2; caspase 3; neuroprotection

Indexed keywords

CASPASE 3; DNA FRAGMENT; FODRIN; PROTEIN BCL XL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOYBEAN; STROKE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; BRAIN; CASPASES; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; FOOD, FORMULATED; INFARCTION, MIDDLE CEREBRAL ARTERY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PHYTOESTROGENS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SOY FOODS; STROKE;

EID: 34548765502     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.06.046     Document Type: Article

References (41)

1. Alkayed N.J., Goto S., Sugo N., Joh H.-D., Klause J., Crain B.J., Bernard O., Traystman R.J., and Hurn P.D. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke. J Neurosci 21 (2001) 7543-7550
2. Alonso de Lecinana M., and Egido J.A. Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc Dis 21 Suppl 2 (2006) 48-53
3. Brass L.M. Hormone replacement therapy and stroke: clinical trials review. Stroke 35 (2004) 2644-2647
4. Burguete M.C., Torregrosa G., Perez-Asensio F.J., Castello-Ruiz M., Salom J.B., Gil J.V., and Alborch E. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats. Eur J Neurosci 23 (2006) 703-710
5. Cao G., Clark R.S., Pei W., Yin W., Zhang F., Sun F.Y., Graham S.H., and Chen J. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J Cereb Blood Flow Metab 23 (2003) 1137-1150
6. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., and Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18 (1998) 4914-4928
7. Daugas E., Nochy D., Ravagnan L., Loeffler M., Susin S.A., Zamzami N., and Kroemer G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476 (2000) 118-123
8. Davoli M.A., Fourtounis J., Tam J., Xanthoudakis S., Nicholson D., Robertson G.S., Ng G.Y.K., and Xu D. Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience 115 (2002) 125-136
9. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neuroscience 19 (1999) 6385-6393
10. Fan T., Yang S.H., Johnson E., Osteen B., Hayes R., Day A.L., and Simpkins J.W. 17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Res 993 (2003) 10-17
11. Ferrer I., Friguls B., Dalfo E., Justicia C., and Planas A.M. Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat. Neuropathol Appl Neurobiol 29 (2003) 472-481
12. Ferrer I., and Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol 62 (2003) 329-339
13. Frankowski H., Missotten M., Fernandez P.A., Martinou I., Michel P., Sadoul R., and Martinou J.C. Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 6 (1995) 1917-1921
14. Gonzalez-Garcia M., Garcia I., Ding L., O'Shea S., Boise L.H., Thompson C.B., and Nunez G. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A 92 (1995) 4304-4308
15. Hatfield R.H., Mendelow A.D., Perry R.H., Alvarez L.M., and Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol 17 (1991) 61-67
16. Kharbanda S., Pandey P., Schofield L., Israels S., Roncinske R., Yoshida K., Bharti A., Yuan Z.M., Saxena S., Weichselbaum R., Nalin C., and Kufe D. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A 94 (1997) 6939-6942
17. Kurzer M.S. Phytoestrogen supplement use by women. J Nutr 133 (2003) 1983S-1986S
18. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
19. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
20. McCullough L.D., and Hurn P.D. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14 (2003) 228-235
21. Merry D.E., and Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20 (1997) 245-267
22. Newton K.M., Buist D.S., Keenan N.L., Anderson L.A., and LaCroix A.Z. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 100 (2002) 18-25
23. Panickar K.S., Nonner D., and Barrett J.N. Overexpression of Bcl-xl protects septal neurons from prolonged hypoglycemia and from acute ischemia-like stress. Neuroscience 135 (2005) 73-80
24. Rami A. Ischemic neuronal death in the rat hippocampus: the calpain-calpastatin-caspase hypothesis. Neurobiol Dis 13 (2003) 75-88
25. Rau S.W., Dubal D.B., Bottner M., Gerhold L.M., and Wise P.M. Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 23 (2003) 11420-11426
26. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
27. Schreihofer D.A., Do K.D., and Schreihofer A.M. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am J Physiol Regul Integr Comp Physiol 289 (2005) R103-R108
28. Setchell K.D. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20 (2001) 354S-362S discussion 381S-383S
29. Shinoura N., Koike H., Furitu T., Hashimoto M., Asai A., Kirino T., and Hamada H. Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy. Hum Gene Ther 11 (2000) 1123-1137
30. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., and Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10 (1990) 290-293
31. Trieu V.N., and Uckun F.M. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 258 (1999) 685-688
32. Vaya J., and Tamir S. The relation between the chemical structure of flavonoids and their estrogen-like activities. Curr Med Chem 11 (2004) 1333-1343
33. Wiessner C., Allegrini P.R., Rupalla K., Sauer D., Oltersdorf T., McGregor A.L., Bischoff S., Bottiger B.W., and van der Putten H. Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci Lett 268 (1999) 119-122
34. Wise P.M., Dubal D.B., Rau S.W., Brown C.M., and Suzuki S. Are estrogens protective or risk factors in brain injury and neurodegeneration?. Reevaluation after the Women's Health Initiative. Endocr Rev 26 (2005) 308-312
35. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., and Böttner M. Minreview: neuroprotective effects of estrogen: new insights into mechanisms of action. Endocrinology 142 (2001) 969-973
36. Won C.K., Kim M.O., and Koh P.O. Estrogen modulates Bcl-2 family proteins in ischemic brain injury. J Vet Med Sci 68 (2006) 277-280
37. Zhang B., Hata R., Zhu P., Sato K., Wen T.C., Yang L., Fujita H., Mitsuda N., Tanaka J., Samukawa K., Maeda N., and Sakanaka M. Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression. J Cereb Blood Flow Metab 26 (2006) 708-721
38. Zhang R., Xue Y.Y., Lu S.D., Wang Y., Zhang L.M., Huang Y.L., Signore A.P., Chen J., and Sun F.Y. Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 24 (2006) 345-356
39. Zhang Y., and Bhavnani B.R. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci 7 (2006) 49
40. Zhao H., Yenari M.A., Cheng D., Barreto-Chang O.L., Sapolsky R.M., and Steinberg G.K. Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab 24 (2004) 681-692
41. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., and Steinberg G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 85 (2003) 1026-1036